Live feed12:45:00·650dPRReleasevia QuantisnowIncyte's CDK2 Inhibitor INCB123667 Shows Promising Evidence of Clinical Activity in Patients with Advanced Solid Tumors, Notably Ovarian CancerByQuantisnow·Wall Street's wire, on your screen.INCY· Incyte Corp.Health Care
